---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-23-294320"
form_type: "8-K"
ticker: "VERU"
cik: "0000863894"
company_name: "VERU INC."
filed_at: "2023-12-13T23:59:59+00:00"
generated_at: "2026-06-07T13:52:23.121682+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# Veru amends Lincoln Park equity facility to $50M; unveils enobosarm GLP-1 combo plan

## Summary
- Amended Lincoln Park agreement reduces registered shares from $100M to $50M until $50M sold; only $3.1M sold to date.
- Plans to develop enobosarm to augment fat loss and prevent muscle loss in elderly on GLP-1 drugs.
- Updated corporate presentation includes enobosarm Phase 2b trial design for sarcopenic obese/overweight patients.

## SEC filing metadata
- accession: 0001193125-23-294320
- form_type: 8-K
- ticker: VERU
- cik: 0000863894
- company_name: VERU INC.
- filed_at: 2023-12-13T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 1.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/863894/000119312523294320/0001193125-23-294320-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/863894/000119312523294320/d568621d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-23-294320
- JSON: https://secwatch.observer/filing/0001193125-23-294320.json
- Plain text: https://secwatch.observer/filing/0001193125-23-294320.txt

## Key facts
- Material Agreements
  VERU INC. amended the Amendment with Lincoln Park Capital Fund, LLC valued at from $100 million to $50 million (effective 2023-12-13).
  - Action: amendment
  - Agreement: equity purchase
  - Counterparty: Lincoln Park Capital Fund, LLC
  - Value: from $100 million to $50 million
  - Effective: 2023-12-13
  source text: On December 13, 2023, the Company entered into an amendment (the “Amendment”) to the Agreements to reduce the amount of shares of common stock subject to the registration under the Agreements from $100 million to $50 million until the Company has sold at least $50 million of shares of common stock under the Purchase Agreement.
  evidence_url: https://www.sec.gov/Archives/edgar/data/863894/000119312523294320/0001193125-23-294320-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.